McKesson Corporation (MCK)

NYQ – Real Time Price. Currency in USD

734.69

+9.52 (1.31%)

At close: May 12, 2026, 4:00 PM EDT

12.05.2026

McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

11.05.2026

McKesson Q4 Earnings Call Highlights

McKesson NYSE: MCK reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispecialty, pharmaceutical distribution and prescription technology businesses, while outlining plans for continued earnings growth in fiscal 2027.

08.05.2026

MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up

McKesson beats Q4 EPS estimates as oncology and specialty distribution growth offset revenue miss and lift segment margins.

08.05.2026

McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript

07.05.2026

Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

07.05.2026

McKesson (MCK) Surpasses Q4 Earnings Estimates

McKesson (MCK) came out with quarterly earnings of $11.69 per share, beating the Zacks Consensus Estimate of $11.56 per share. This compares to earnings of $10.12 per share a year ago.

07.05.2026

McKesson expects 2027 profit slightly above estimates on drug distribution strength

McKesson forecast 2027 profit slightly above Wall Street expectations after beating first-quarter profit estimates on Thursday, as the U.S. drug distributor ‌banks on strength in its oncology and specialty drug businesses.

Videos

05.01.2026

Neutral

Final Trades: Lockheed Martin, QXO and McKesson Corporation

19.11.2025

Neutral

Final Trades: Freeport-McMoRan, Cisco, Teradyne and McKesson Corp.

Press releases

07.05.2026

McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 7, at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arch.

22.04.2026

McKesson Corporation Declares Quarterly Dividend

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers,.

20.04.2026

McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, today announced it has entered into a definitive agreement with funds managed by affiliates of Apollo (“Apollo Funds”), under which Apollo Funds will acquire a minority ownership interest in McKesson's Medical-Surgical Solutions (“MMS”) business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public o.

19.03.2026

McKesson ideaShare 2026 Invites Independent Pharmacists to Learn, Connect and Grow

IRVING, Texas--(BUSINESS WIRE)--Registration is now open for McKesson ideaShare 2026, a premier community pharmacy event for independent pharmacy owners and their teams.

McKesson Corporation (MCK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

McKesson Corporation (MCK)